Private company
STREAMLINE HEALTH SOLUTIONS INC.
STREAMLINE HEALTH SOLUTIONS INC. is an American computer integrated systems design services company based in Atlanta.2
Last updated Oct 20, 2026.
Overview
- IndustryServices-Computer Integrated Systems Design2
- HeadquartersAtlanta, United States2
- Incorporated inDE4
- Business address2400 Old Milton Parkway, Box 1353, Alpharetta, Ga 300094
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI5493005R8JNDFOLVG7642
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 25851392
See how the biggest companies compare on our leaderboards
Incorporated in 1989, Streamline Health Solutions, Inc. is a provider of solutions and services in the middle of the revenue cycle for healthcare providers throughout the United States and Canada. Streamline Health’s technology helps hospitals improve their financial performance by optimizing data and coding for every patient encounter prior to bill submission. By performing these activities before billing, providers can drive net revenue through reduced revenue leakage, overbilling, and days in accounts receivable. This enables providers to achieve more predictable revenue streams using technology rather than manual intervention.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development28¢$4.6M
- Selling, general and admin72¢$11.7M
Out of $4.8M in revenue.37 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.3M8 | $22.4M9 | $11.9M10 | $11.3M11 | $17.4M12 | $24.9M13 | $4.3M3 | $4.8M3 |
| Cost of revenue | $1.9M16 | |||||||
| Gross profit | ||||||||
| Research and development | $5.4M8 | $2.7M10 | $2.7M10 | $2.9M11 | $4.8M12 | $6.0M13 | $5.7M7 | $4.6M7 |
| Selling, general and admin | $11.4M8 | $10.6M9 | $9.6M10 | $8.6M11 | $11.9M12 | $16.3M13 | $14.7M7 | $11.7M7 |
| Operating expenses | $28.1M12 | $35.7M13 | $6.6M3 | $5.9M3 | ||||
| Operating income | -$2.6M8 | -$5.3M9 | -$7.2M10 | -$5.9M11 | -$10.8M12 | -$10.8M13 | -$2.2M3 | -$1.1M3 |
| Interest | $474.0K8 | $384.0K9 | $309.0K10 | $51.0K11 | $236.0K12 | $749.0K13 | $1.1M13 | |
| Income before tax | -$6.8M12 | -$11.3M13 | -$2.7M3 | -$1.6M3 | ||||
| Income tax | -$84.0K8 | -$1.6M10 | -$1.3M11 | $109.0K12 | $71.0K13 | $03 | $03 | |
| Net income | -$3.1M8 | -$5.9M9 | -$2.9M10 | $296.0K11 | -$6.5M12 | -$11.4M13 | -$2.7M3 | -$1.6M3 |
| Earnings per share | -$0.168 | -$0.309 | $0.0810 | $0.0111 | -$0.2313 | -$0.3313 | -$4.967 | -$2.537 |
| Earnings per share (diluted) | -$0.168 | -$0.309 | -$0.1410 | $0.0111 | -$0.2313 | -$0.3313 | -$4.967 | -$2.537 |
| Shares (weighted, basic) | 42.8M shares12 | 49.3M shares13 | 3.8M shares7 | 4.0M shares7 | ||||
| Shares (weighted, diluted) | 43.3M shares12 | 49.3M shares13 | 3.8M shares7 | 4.0M shares7 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash | $4.6M8 | $2.4M9 | $1.6M10 | $2.4M11 | $9.9M12 | $6.6M13 | $3.2M7 | $2.2M7 |
| Receivables | $3.8M12 | $7.7M13 | $4.2M7 | $1.6M7 | ||||
| Current assets | $9.6M8 | $7.6M9 | $6.6M10 | $7.3M11 | $15.1M12 | $16.0M13 | $8.8M7 | $5.8M7 |
| Property, plant and equipment | $79.0K13 | $88.0K7 | $49.0K7 | |||||
| Goodwill | $23.1M12 | $23.1M7 | $13.3M7 | $13.3M7 | ||||
| Intangible assets | $16.8M12 | $14.8M13 | $12.1M7 | $10.4M7 | ||||
| Total assets | $37.1M8 | $31.7M9 | $31.7M10 | $26.0M11 | $61.8M12 | $61.5M13 | $41.7M7 | $35.6M7 |
| Accounts payable | $778.0K12 | $626.0K13 | $1.3M7 | $1.5M7 | ||||
| Short-term debt | $250.0K12 | $750.0K13 | $1.5M13 | $137 | ||||
| Current liabilities | $11.5M8 | $12.1M9 | $15.6M10 | $7.4M11 | $13.5M12 | $16.8M13 | $13.7M7 | $23.1M7 |
| Long-term debt | $3.4M9 | $3.9M10 | $767.0K11 | $9.7M12 | $9.0M13 | $7.6M13 | ||
| Long-term liabilities | $14.3M12 | $9.2M13 | $9.2M7 | $240.0K7 | ||||
| Total liabilities | $18.4M8 | $16.9M9 | $15.7M10 | $8.5M11 | $27.8M12 | $26.0M13 | $22.9M7 | $23.3M7 |
| Retained earnings | -$85.7M12 | -$97.0M13 | -$115.7M7 | -$125.9M7 | ||||
| Shareholders’ equity | $9.9M9 | $6.2M10 | $16.0M11 | $17.5M12 | $34.0M13 | $35.5M7 | $18.8M7 | $12.3M7 |
| Shares outstanding | 20.0M shares16 | 20.9M shares8 | 30.9M shares9 | 42.3M shares10 | 48.1M shares11 | 58.6M shares12 | 65.4M shares13 | 4.3M shares17 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $2.0M8 | $1.4M9 | -$8.0K9 | -$7.1M13 | -$2.2M7 | -$1.5M7 | ||
| Depreciation and amortization | $3.7M12 | $4.3M13 | $4.3M7 | $4.9M7 | ||||
| Stock-based compensation | $2.2M12 | $1.7M13 | $2.1M7 | $2.0M7 | ||||
| Capital spending | $49.0K8 | $21.0K9 | $52.0K10 | $44.0K11 | $41.0K12 | $10.0K13 | $54.0K7 | $7.0K7 |
| Free cash flow | $2.0M | $1.4M | -$60.0K | -$7.2M | -$2.3M | -$1.5M | ||
| Cash from investing | -$13.2M12 | -$1.9M13 | -$1.6M7 | -$858.0K7 | ||||
| Cash from financing | $24.1M12 | $5.8M13 | $428.0K7 | $1.4M7 |
Compare STREAMLINE HEALTH SOLUTIONS INC. with another company
Corporate structure
STREAMLINE HEALTH SOLUTIONS INC. sits at the top of its group. 5 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of STREAMLINE HEALTH SOLUTIONS INC.
- Beryl Capital Management LLC Filed SCHEDULE 13G/A on STREAMLINE HEALTH SOLUTIONS INC., latest Nov 14, 2025 (2 filings since Jun 5, 2025)
- Harbert Discovery Fund, LP Filed SCHEDULE 13D/A on STREAMLINE HEALTH SOLUTIONS INC., latest Aug 14, 2025 (2 filings since Jun 2, 2025)
- Tamarack Advisers, LP Filed SCHEDULE 13D on STREAMLINE HEALTH SOLUTIONS INC., latest Nov 22, 2024 (3 filings since Dec 1, 2022)
- Justin John Ferayorni Filed SCHEDULE 13D on STREAMLINE HEALTH SOLUTIONS INC., latest Jul 17, 2024
- GCI Partners Opportunity Fund, LP Filed SC 13G on STREAMLINE HEALTH SOLUTIONS INC., latest Sep 27, 2023 (2 filings since Apr 14, 2022)
- Marathon Micro Fund, LP Filed SC 13G/A on STREAMLINE HEALTH SOLUTIONS INC., latest Feb 3, 2023 (2 filings since Jul 11, 2022)
- Norman H. Pessin Filed SC 13D/A on STREAMLINE HEALTH SOLUTIONS INC., latest Nov 1, 2022
- Nantahala Capital Management, LLC Filed SC 13G/A on STREAMLINE HEALTH SOLUTIONS INC., latest Feb 14, 2022
- STREAMLINE HEALTH SOLUTIONS INC. Atlanta, Georgia, United States
- Avelead Consulting, LLC Subsidiary · Delaware, United States
- Streamline Consulting Solutions, LLC Subsidiary · Delaware, United States
- Streamline Health, LLC Subsidiary · Delaware, United States
- Streamline Pay & Benefits, LLC Subsidiary · Delaware, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What STREAMLINE HEALTH SOLUTIONS INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated depreciation | $110.0K7 Jan 31, 2025 | $291.0K7 Jan 31, 2024 | −62.2% |
| Property and equipment, net | $49.0K7 Jan 31, 2025 | $88.0K7 Jan 31, 2024 | −44.3% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $13.3M7 Jan 31, 2025 | $13.3M7 Jan 31, 2024 | 0% |
| Intangible assets, net (excluding goodwill) | $10.4M7 Jan 31, 2025 | $12.1M7 Jan 31, 2024 | −13.6% |
| Finite-lived intangibles, gross | $16.1M7 Jan 31, 2025 | $16.1M7 Jan 31, 2024 | 0% |
| Accumulated amortization | $5.7M7 Jan 31, 2025 | $4.0M7 Jan 31, 2024 | +40.7% |
| Finite-lived intangibles, net | $10.4M7 Jan 31, 2025 | $12.1M7 Jan 31, 2024 | −13.6% |
Properties, in its own words
In March 2020, the Company moved its principal offices to a subleased office space at 11800 Amber Park Drive, Suite 125, Alpharetta, Georgia 30009. The office space totals 7,409 square feet and the sublease expired on March 31, 2023. In October 2021, we subleased this space to a third party for the remaining lease period.
On August 16, 2021, contemporaneous with the acquisition of Avelead, the Company assumed a lease of office space at 1172 Satellite Boulevard NW, Office Suite 100, Suwannee, Georgia 30024. The lease expired on February 28, 2022. The lease was renewed in February 2022 for one year on substantially the same terms. The tenant of the lease is an entity controlled by the former owner of Avelead and former Chief Strategy Officer of the Company. The lease expired on February 28, 2023 and was not renewed.
The rest of Item 2
The Company relies on a virtual office model and does not have a physical office space. Membership agreements and daily space rentals are leveraged by the Company when groups need to meet in person. Our mailing address is 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009. We believe the virtual environment is adequate for the Company’s current and planned future operations. Suitable alternative space is available to accommodate the expansion of the Company’s operations.
Item 2 of the 10-K filed May 2, 2025.6
Leadership
Who has led STREAMLINE HEALTH SOLUTIONS INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerBenjamin Louis Stilwill Nov 3, 2023 to now18
- Chief executive officerWyche T. Green Iii. Jul 31, 2019 to May 24, 202319
- Chief executive officerDavid William Sides Jan 12, 2015 to Jun 19, 201920
- Chief executive officerRobert Eugene Watson Feb 2, 2011 to Sep 22, 201421
- Chief executive officerJ. Brian Patsy Mar 7, 2006 to Dec 20, 201022
- ChairWyche T. Green Iii. Aug 14, 2025 to now23
- PresidentBenjamin Louis Stilwill Nov 2, 2022 to now24
- PresidentWyche T. Green Iii. Jul 31, 2019 to May 24, 202319
- PresidentDavid William Sides Jan 12, 2015 to Jun 19, 201920
- PresidentRobert Eugene Watson Feb 2, 2011 to Sep 22, 201421
- PresidentJ. Brian Patsy Mar 7, 2006 to Dec 20, 201022
- Chief financial officerBryant J. Reeves Iii. Oct 19, 2023 to now25
- Chief financial officerThomas J. Gibson Sep 13, 2018 to Nov 2, 202326
- Chief financial officerNicholas Meeks May 24, 2013 to Jul 13, 201827
- Chief financial officerDonald E. Vick Jr. Jan 28, 2009 to Apr 19, 201028
- Chief financial officerPaul W. Bridge Jr. May 26, 2006 to Jun 30, 200629
- Chief operating officerWilliam George Garvis Aug 5, 2019 to Feb 2, 202230
- Chief operating officerRichard Nelli Aug 25, 2014 to Aug 25, 201431
- Chief operating officerDavid William Sides Sep 12, 2014 to Dec 29, 201432
- Chief operating officerWilliam A. Geers Jun 5, 2007 to Jun 6, 200733
Board members and other officers (33)
- Chief People OfficerWendy L. Lucio Jul 27, 2022 to now34
- Principal Accounting OfficerLuciana Mullen Jun 28, 2018 to Jul 29, 201935
- SVP & Chief Growth OfficerShaun Linwood Priest Apr 8, 2016 to Apr 9, 201836
- SVP, Adm. & Ch. Legal CounselJack William Kennedy Jr. Sep 2, 2015 to Mar 28, 201637
- SVP & Chief People OfficerLois Elizabeth Rickard Apr 4, 2014 to Sep 2, 201538
- SVP & Chief Marketing OfficerRandolph Salisbury Apr 4, 2014 to Mar 8, 202239
- ControllerMichael W. Halloran Aug 13, 2014 to May 2, 201640
- Sr. Vice President, StrategyMatthew Stephen Seefeld Jan 4, 2013 to Apr 3, 201441
- Sr. Vice President, Client SerHerbert P. Larsen Mar 5, 2013 to Jan 17, 201442
- Sr. Vice President, CTORichard Nelli Mar 5, 2013 to Feb 24, 201443
- Chief Accounting OfficerCarolyn Zelnio May 24, 2013 to May 24, 201344
- Sr. Vice President, SalesMichael A. Schiller Mar 1, 2012 to Jan 17, 201445
- Chief Marketing OfficerDonald Leach Richard Mar 14, 2011 to Oct 30, 201246
- VICE PRESIDENTB. Scott Boyden Jr. Jun 26, 2008 to Jun 30, 200947
- Vice PresidentGary M. Winzenread Oct 4, 2007 to Aug 3, 201248
- Vice PresidentJoseph O. Brown Ii. Oct 4, 2007 to Apr 8, 201049
- Assistant TreasurerDonald E. Vick Jr. Jun 30, 2006 to Dec 5, 200650
- Board memberMatthew Etheridge Feb 8, 2024 to now51
- Board memberBenjamin Louis Stilwill May 1, 2024 to now52
- Board memberJustin John Ferayorni May 26, 2020 to now53
- Board memberKenan Lucas Jan 23, 2018 to now54
- Board memberWyche T. Green Iii. Aug 16, 2018 to now55
- Board memberDavid William Sides Jan 13, 2015 to Jun 19, 201956
- Board memberJudith Starkey Oct 1, 2014 to now57
- Board memberMichael K. Kaplan Feb 3, 2012 to Jun 7, 201758
- Board memberAllen S. Moseley Oct 16, 2012 to Oct 16, 201259
- Board memberMichael G. Valentine Oct 17, 2012 to Jun 6, 201760
- Board memberRobert Eugene Watson Feb 2, 2011 to Jan 22, 201521
- Board memberJay D. Miller Feb 27, 2009 to Oct 30, 201261
- Board memberJ. Brian Patsy Mar 7, 2006 to Dec 20, 201022
- Board memberEdward Vonderbrink May 25, 2006 to Aug 25, 201462
- Board memberAndrew L. Turner Nov 22, 2006 to Jan 22, 201563
- General counselJack William Kennedy Jr. Oct 4, 2013 to Jul 10, 201564
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Avelead Consulting, LLC Delaware5
- Streamline Consulting Solutions, LLC Delaware5
- Streamline Health, LLC Delaware5
- Streamline Pay & Benefits, LLC Delaware5
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Aug 13, 20258-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer65
- Aug 7, 20258-K Shareholder vote; Other events66
- Jul 1, 20258-K Entered a material agreement; New debt or obligation; Executive or director change67
- Jun 16, 20258-K Results of operations; Other events68
- May 29, 20258-K Entered a material agreement; Regulation FD disclosure69
- May 1, 20258-K Results of operations70
- Mar 28, 20258-K Entered a material agreement; New debt or obligation71
- Dec 16, 20248-K Results of operations72
- Nov 15, 20248-K Entered a material agreement; New debt or obligation73
- Sep 26, 20248-K Change to shareholders' rights; Bylaws or fiscal year changed; Regulation FD disclosure74
- Sep 19, 20248-K Shareholder vote75
- Sep 11, 20248-K Results of operations76
- Nov 3, 2023New chief executive Benjamin Louis Stilwill becomes CEO18
- Jul 31, 2019New chief executive Wyche T. Green Iii. becomes CEO19
- Jan 12, 2015New chief executive David William Sides becomes CEO20
- Feb 2, 2011New chief executive Robert Eugene Watson becomes CEO21
- Mar 7, 2006New chief executive J. Brian Patsy becomes CEO22
- Feb 7, 1996Founded STREAMLINE HEALTH SOLUTIONS INC. is founded2
Calendar
When it reported results
- Jun 16, 2025Reported quarterly or annual results68
- May 1, 2025Reported quarterly or annual results70
- Dec 16, 2024Reported quarterly or annual results72
- Sep 11, 2024Reported quarterly or annual results76
- Jun 11, 2024Reported quarterly or annual results77
- Apr 29, 2024Reported quarterly or annual results78
- Dec 14, 2023Reported quarterly or annual results79
- Sep 14, 2023Reported quarterly or annual results80
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
218 filings to the SEC since October 2021: 6 annual reports, 11 quarterly reports, 41 major events, 85 insider forms, 14 large holders, 61 other. The latest 20:
- Nov 14, 2025SCHEDULE 13G/A EDGAR
- Aug 22, 202515-12G EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 15, 2025EFFECT EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025POS AM EDGAR
- Aug 14, 2025S-8 POS EDGAR
- Aug 14, 2025S-8 POS EDGAR
- Aug 14, 2025S-8 POS EDGAR
- Aug 14, 2025S-8 POS EDGAR
The 218 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 20, 2024 | Stilwill Benjamin LouisPresident and CEO | Buy | 6,300 | $0.16 | $1.0K | Form 4 |
| Oct 26, 2022 | LUCAS KENANDirector | Buy | 757,575 | $1.32 | $1.0M | Form 4 |
| Dec 16, 2021 | LUCAS KENANDirector | Buy | 100,000 | $1.50 | $150.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Beryl Capital Management LLCSCHEDULE 13G/A, 2 filings Jun 5, 2025 to Nov 14, 202581
- Harbert Discovery Fund, LPSCHEDULE 13D/A, 2 filings Jun 2, 2025 to Aug 14, 202582
- Tamarack Advisers, LPSCHEDULE 13D, 3 filings Dec 1, 2022 to Nov 22, 202483
- Justin John FerayorniSCHEDULE 13D, 1 filing Jul 17, 202484
- GCI Partners Opportunity Fund, LPSC 13G, 2 filings Apr 14, 2022 to Sep 27, 202385
- Marathon Micro Fund, LPSC 13G/A, 2 filings Jul 11, 2022 to Feb 3, 202386
- Norman H. PessinSC 13D/A, 1 filing Nov 1, 202287
- Nantahala Capital Management, LLCSC 13G/A, 1 filing Feb 14, 202288
SEC filer profile
How STREAMLINE HEALTH SOLUTIONS INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSTREAMLINE HEALTH SOLUTIONS INC.1
- CIK0001008586
- Employer ID (EIN)31-14554146
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company6
- Incorporated inDelaware6
- Fiscal year endsJanuary 311
- Industry code (SIC)7373 Services-Computer Integrated Systems Design1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address2400 Old Milton Parkway, Box 1353, Alpharetta, GA 300091
- Phone888-997-87321
- Shares outstanding4,356,062 as of Jun 12, 20253
- Public float$23.5M as of Jul 31, 20246
- AuditorForvis Mazars, LLP, Atlanta, Georgia PCAOB ID 686; no auditor attestation of internal control over financial reporting6
- On EDGAR sinceJun 12, 19961
- Filings1,246 in all: 4 (544), 8-K (250), 10-Q (88), 3 (43), SC 13G/A (41), DEF 14A (31), 10-K (24), SC 13G (24)1
All 48 form types
EFFECT (17), S-8 (17), 4/A (16), S-8 POS (13), CORRESP (12), UPLOAD (12), SC 13D/A (11), DEFA14A (10), S-3 (10), POS AM (7), PRE 14A (7), S-3/A (7), 424B5 (6), 8-K/A (6), 10-K405 (5), SC 13D (5), 10-K/A (4), NT 10-Q (4), 10-Q/A (3), 3/A (2), ARS (2), D (2), DEFM14A (2), NT 10-K (2), PREM14A (2), SCHEDULE 13D (2), SCHEDULE 13D/A (2), 144 (1), 15-12G (1), 25-NSE (1), 424B2 (1), 424B3 (1), 5 (1), 8-A12G/A (1), DEFS14A (1), DEL AM (1), NO ACT (1), PRES14A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (10-K) May 2, 2025
Quarterly report (10-Q) Jun 16, 2025
Proxy statement (DEF 14A) Aug 19, 2024
Latest 8-K (8-K) Aug 13, 2025
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.01 par value per share | STRM | Nasdaq |
From the cover page of the 10-K filed May 2, 2025 (Section 12(b) of the Exchange Act).6
Risk factors and legal proceedings
The risks STREAMLINE HEALTH SOLUTIONS INC. names in Item 1A of its 10-K filed May 2, 2025: 37 risks under these headings, as written.6
- Risks Relating to Our Business
- Our sales have been concentrated in a small number of clients.
- Over the last several years, we have completed acquisitions, and may undertake additional acquisitions in the future. Any failure to adequately integrate past and future acquisitions into our business could have a material adverse effect on us.
- We could consume resources in researching acquisitions, business opportunities or financings and capital market transactions that are not ultimately consummated, which could materially adversely affect our financial condition and subsequent attempts to locate and acquire or invest in another business.
- A significant increase in new SaaS contracts could require a significant cash outlay, which could adversely affect near term cash flow.
- We may not see the anticipated market interest or growth in our software solutions. In addition, coding audit services and associated software and technologies represent a new market for the Company, and we may not see the anticipated market interest or growth due to being a new player in the industry.
- Clients may exercise termination rights within their contracts, which may cause uncertainty in anticipated and future revenue streams.
- Changes in healthcare regulations impacting coding, payers and other aspects of the healthcare regulatory cycle could have substantial impact on our financial performance, growth and operating costs.
- The potential impact on us of new or changes in existing federal, state and local regulations governing healthcare information could be substantial.
- The healthcare industry is highly regulated. Any material changes in the political, economic or regulatory healthcare environment that affect the group purchasing business or the purchasing practices and operations of healthcare organizations, or that lead to consolidation in the healthcare industry, could require us to modify our services or reduce the funds available to providers to purchase our solutions and services.
- We face significant competition, including from companies with significantly greater resources.
- The healthcare industry is evolving rapidly, which may make it more difficult for us to be competitive in the future.
The other 26 risks
- Rapid technology changes and short product life cycles could harm our business.
- Our intellectual property rights are valuable, and any inability to protect them could reduce the value of our solutions and services.
- We could be subjected to claims of intellectual property infringement that could be expensive to defend.
- If we are unable to maintain effective internal control over financial reporting, we may fail to prevent or detect material misstatements in our financial statements, in which case investors may lose confidence in the accuracy and completeness of our financial statements.
- Third party products are essential to our software.
- Our solutions may not be error-free and could result in claims of breach of contract and liabilities.
- We could be liable to third parties from the use of our solutions.
- Our SaaS and support services could experience interruptions.
- Our business and operations would suffer in the event of computer system failures, cyber-attacks or a deficiency in our cybersecurity. Our SaaS solutions are provided over an internet connection and any breach of security or confidentiality of protected health information could expose us to significant expense and harm our reputation.
- The loss of key personnel could adversely affect our business.
- Our future success depends upon our ability to grow, and if we are unable to manage our growth effectively, we may incur unexpected expenses and be unable to meet our clients’ requirements.
- We may not have access to sufficient or cost-efficient capital to support our growth, execute our business plans and remain competitive in our markets.
- Unstable market and economic conditions and potential disruptions in the credit markets may adversely affect our business, including the availability and cost of short-term funds for liquidity requirements and our ability to meet long-term commitments, which could adversely affect our results of operations, cash flows and financial condition.
- We must maintain compliance with the terms of our existing credit facilities or receive a waiver for any non-compliance. The failure to maintain compliance could have a material adverse effect on our ability to finance our ongoing operations and we may not be able to find an alternative lending source if a default occurs.
- Economic conditions in the U.S. and globally may have significant effects on our clients and suppliers that could result in material adverse effects on our business, operating results and stock price.
- The variability of our quarterly operating results can be significant.
- Our business, results of operations and financial condition has been, and may continue to be, materially adversely affected by the COVID-19 pandemic.
- The preparation of our financial statements requires the use of estimates that may vary from actual results.
- Failure to improve and maintain the quality of internal control over financial reporting and disclosure controls and procedures or other lapses in compliance could materially and adversely affect our ability to provide timely and accurate financial information about us or subject us to potential liability.
- Risks Relating to our Common Stock
- The market price of our common stock is likely to be highly volatile as the stock market in general can be highly volatile.
- All of our debt obligations and any preferred stock that we may issue in the future will have priority over our common stock with respect to payment in the event of a bankruptcy, liquidation, dissolution or winding up.
- There may be future sales or other dilution of our equity, which may adversely affect the market price of our common stock.
- The issuance of preferred stock could adversely affect holders of shares of our common stock, which may negatively impact your investment.
- We do not currently intend to pay dividends on our common stock and, consequently, your ability to achieve a return on your investment will depend solely on appreciation in the price of our common stock.
- Sales of shares of our common stock or securities convertible into our common stock in the public market may cause the market price of our common stock to fall.
- If we are unable to maintain compliance with Nasdaq listing requirements, our stock could be delisted, and the trading price, volume and marketability of our stock could be adversely affected.
- Note Regarding Risk Factors
Legal proceedings
We are, from time to time, a party to various legal proceedings and claims, which arise in the ordinary course of business. We are not aware of any legal matters that could have a material adverse effect on our consolidated results of operations, financial position or cash flows.
The opening of Item 3, Legal Proceedings.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23SEC EDGARWyche T. Green Iii., Chair
- 24SEC EDGARBenjamin Louis Stilwill, President
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34SEC EDGARWendy L. Lucio, Chief People Officer
- 35
- 36
- 37
- 38
- 39
- 40SEC EDGARMichael W. Halloran, Controller
- 41
- 42
- 43
- 44
- 45
- 46
- 47SEC EDGARB. Scott Boyden Jr., VICE PRESIDENT
- 48SEC EDGARGary M. Winzenread, Vice President
- 49SEC EDGARJoseph O. Brown Ii., Vice President
- 50
- 51SEC EDGARMatthew Etheridge, Board member
- 52
- 53SEC EDGARJustin John Ferayorni, Board member
- 54SEC EDGARKenan Lucas, Board member
- 55SEC EDGARWyche T. Green Iii., Board member
- 56SEC EDGARDavid William Sides, Board member
- 57SEC EDGARJudith Starkey, Board member
- 58SEC EDGARMichael K. Kaplan, Board member
- 59SEC EDGARAllen S. Moseley, Board member
- 60SEC EDGARMichael G. Valentine, Board member
- 61SEC EDGARJay D. Miller, Board member
- 62SEC EDGAREdward Vonderbrink, Board member
- 63SEC EDGARAndrew L. Turner, Board member
- 64
- 65
- 66SEC EDGARShareholder vote; Other events
- 67
- 68SEC EDGARResults of operations; Other events
- 69
- 70SEC EDGARResults of operations
- 71
- 72SEC EDGARResults of operations
- 73
- 74
- 75SEC EDGARShareholder vote
- 76SEC EDGARResults of operations
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88